Abstract
Understanding the complex causal relationships among major clinical outcomes and the causal interplay among multiple organs remains a significant challenge. By using imaging phenotypes, we can characterize the functional and structural architecture of major human organs. Mendelian randomization (MR) provides a valuable framework for inferring causality by leveraging genetic variants as instrumental variables. In this study, we conducted a systematic multi-organ MR analysis involving 402 imaging traits and 372 clinical outcomes. Our analysis revealed 184 genetic causal links for 58 diseases and 56 imaging traits across various organs, tissues, and systems, including the brain, heart, liver, kidney, lung, pancreas, spleen, adipose tissue, and skeletal system. We identified intra-organ causal connections, such as the bidirectional genetic links between Alzheimer’s disease and brain function, as well as inter-organ causal effects, such as the impact of heart diseases on brain health. Metabolic disorders, such as diabetes, exhibited causal effects across multiple organs. These findings shed light on the genetic causal links spanning multiple organs, providing insights into the intricate relationships between organ functions and clinical outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the National Institute On Aging of the National Institutes of Health under Award Number RF1AG082938. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study has also been partially supported by funding from the Wharton Dean's Research Fund, Analytics at Wharton, and Purdue Statistics Department. Assistance for this project was also provided by the UNC Intellectual and Developmental Disabilities Research Center (NICHD; P50 HD103573).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the UK Biobank study was secured from the North West Multicentre Research Ethics Committee (approval number: 11/NW/0382).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Lead contact: Bingxin Zhao, 413 Academic Research Building, 265 South 37th Street, Philadelphia, PA 19104., E-mail: bxzhao{at}upenn.edu Phone: (215) 898-8222
Update the FinnGene data resources. Improve the interpretation of findings.
Data Availability
We used summary-level GWAS data in this study, which can be obtained from the FinnGen project (https://www.finngen.fi/en/access_results), BIG-KP (https://bigkp.org/), Heart-KP (https://heartkp.org/), and project-specific resources detailed in Liu., et al and Kun., et al. Our multi-organ MR results can be explored at https://mr4mo.org/
